FindTrial
Sign In

Effects of topical eye drops on the control of early myopia in children

Effects of topical eye drops on the control of early myopia in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058032
Enrollment
Unknown
Registered
2022-03-27
Start date
2022-03-17
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early myopia in children

Interventions

Group 1:0.01% atropine
Group 2:Travatan
Group 3:Cartelol
Control group:Sodium hyaluronate

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 6 Years

Inclusion criteria

Inclusion criteria: Children under 6 years of age with myopia were excluded from other fundus organic lesions.

Exclusion criteria

Exclusion criteria: Severe drug allergic reactions or side effects, or patients lost to follow-up.

Design outcomes

Primary

MeasureTime frame
axis oculi;diopter;intraocular pressure;—

Secondary

MeasureTime frame
eyesight;corneal curvature;fundus examination;—

Countries

China

Contacts

Public ContactXiang Qin

Children's Hospital of Chongqing Medical University

164233023@qq.com+86 18723025290

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026